Abstract | OBJECTIVE: METHODS: Infants with hemangiomas who had received long-pulse 1,064-nm Nd:YAG laser treatment in our department in the last 5 years were recruited. Demographic and clinical characteristics were recorded and outcomes of long-pulse 1,064-nm Nd:YAG laser treatment were assessed. Statistical analyses were performed to identify factors that affected the efficacy of treatment. RESULTS: The efficacy of long-pulse 1,064-nm Nd:YAG laser for the treatment of IHs in all patients in our study was 87.57%. Efficacy did not depend on sex or the location of the lesion. Older age and superficial hemangioma were the primary factors contributing to greater efficacy of long-pulse 1,064-nm Nd:YAG laser treatment for IHs. The most common side effects were pigment changes, skin atrophy, and wrinkled redundant skin, which usually resolved spontaneously within 1 to 3 years. CONCLUSIONS: Long-pulse 1,064-nm Nd:YAG laser is a safe and efficacious treatment for IHs.
|
Authors | Shu-xia Zhong, Yu-chun Tao, Jun-feng Zhou, Yuan-yuan Liu, Lei Yao, Shan-shan Li |
Journal | Pediatric dermatology
(Pediatr Dermatol)
2015 Jul-Aug
Vol. 32
Issue 4
Pg. 495-500
ISSN: 1525-1470 [Electronic] United States |
PMID | 25950113
(Publication Type: Journal Article)
|
Copyright | © 2015 Wiley Periodicals, Inc. |
Topics |
- Female
- Hemangioma, Capillary
(radiotherapy)
- Humans
- Infant
- Infant, Newborn
- Laser Therapy
(methods)
- Lasers, Solid-State
- Male
- Skin Neoplasms
(radiotherapy)
- Treatment Outcome
|